Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Advocates often highlight the possibility for significant therapeutic gains, principally in diseases where conventional therapies have proven limited. However, crucially important to assess the considerable financial expenditure associated with CPI stem